Abstract: Recently, the preparation of regulatory documentation for the approval of pharmaceutical products has been the most crucial and challenging process. However, before submission, the required documents must be set to ensure a seamless, effective procedure that prioritizes safety and maintains quality requirements. The regulatory clearance process can be expedited by using the Quality by Design (QbD) methodology, which is essential for preparing the regulatory documents. QbD has a strong emphasis on the application of scientific design approaches, process understanding, and systematic assessment of risk to the pharmaceutical industry, and thus incorporates quality into the products. In order to assure product quality, consistency, and flexibility in the regulatory environment, QbD includes technologies such as lifecycle management, process analytical technology, and design of experiments. Despite challenges like the complexity of data and a lack of resources, QbD offers advantages like reduction of validation requirements, fast processes for approval, and enhanced regulatory communication, especially in emerging markets. This editorial provides an extensive summary of the complex process of applying QbD in the pharmaceutical regulatory approval, focusing on some ideas, efficient procedures, and possible future applications of the technology.
Lo et al. (Wed,) studied this question.